On the other hand, clear cell carcinoma’s relatively better prognosis may be linked to its distinct molecular profile, characterized by frequent ARID1A and PIK3CA mutations, which could offer actionable therapeutic targets [18,19]. The gene discussed is ARID1A; the disease is clear cell adenocarcinoma.